PC
ONCE

Pier Capital’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Pier Capital’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-110,288
Closed -$6.65M – 134
2015
Q2 		$6.65M Buy
+110,288
New +$7.29M 0.96% 58

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RS Investment Management
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Pier Capital's ONCE Position: Q3 2015 in Review

Pier Capital sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2015, closing a stake of 110,288 shares — an estimated $6.65M sold.

Pier Capital first reported a position in ONCE in Q2 2015 and held it in 1 quarter. The position peaked at $6.65M in Q2 2015. 90 funds tracked by Wall St. Rank hold ONCE as of Q3 2015.

  • Pier Capital reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Pier Capital sold 110,288 Spark Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $6.65M.
  • Pier Capital first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2015 and held it in 1 quarter.
  • Pier Capital's Spark Therapeutics, Inc. Common Stock position peaked at $6.65M in Q2 2015.
  • 90 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Pier Capital's 13F filing for Q3 2015, filed 10 Nov 2015.